Pyrimidine derivatives for use as anticancer agents

Details for Australian Patent Application No. 2006231116 (hide)

Owner AstraZeneca AB

Inventors Thomas, Andrew Peter; Nowak, Thorsten

Agent Davies Collison Cave

Pub. Number AU-A-2006231116

PCT Pub. Number WO2006/106307

Priority 0506883.8 05.04.05 GB; 0525953.6 21.12.05 GB

Filing date 31 March 2006

Wipo publication date 12 October 2006

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/106307 Priority application(s): WO2006/106307

13 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006231117-Therapeutic use of nefopam and analogues thereof

2006231109-Wax-containing materials